Alam Kamran insider trades
Alam Kamran has filed 18 Form 4s with the SEC that we hold, all for Taysha Gene Therapies, Inc. (TSHA), as CHIEF FINANCIAL OFFICER. Across all of them we count 0 purchases worth $0 and 14 sales worth $1.4M reported on Form 4. In the last 12 months: 0 purchases ($0) and 3 sales ($492.5K). The largest single trade was a sale of 78,968 shares of Taysha Gene Therapies, Inc. worth $375.1K, dated 2026-01-23. The first filing on our record is dated 2021-08-20 and the latest 2026-02-06.
Taysha Gene Therapies, Inc. (TSHA)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2021-08-18 | S, sale reported on Form 4 | 11,193 | $194.2K | 2021-08-20 | SEC |
| 2021-08-19 | S, sale reported on Form 4 | 9,354 | $153.7K | 2021-08-20 | SEC |
| 2021-08-19 | S, sale reported on Form 4 | 613 | $10.5K | 2021-08-20 | SEC |
| 2021-08-20 | S, sale reported on Form 4 | 2,094 | $35.9K | 2021-08-20 | SEC |
| 2021-08-20 | S, sale reported on Form 4 | 9,746 | $162.8K | 2021-08-20 | SEC |
| 2022-08-18 | S, sale reported on Form 4 | 7,476 | $28.9K | 2022-08-22 | SEC |
| 2022-08-19 | S, sale reported on Form 4 | 11,482 | $43.1K | 2022-08-22 | SEC |
| 2022-08-22 | S, sale reported on Form 4 | 9,717 | $34.0K | 2022-08-22 | SEC |
| 2022-08-23 | S, sale reported on Form 4 | 3,325 | $11.5K | 2022-08-24 | SEC |
| 2023-08-24 | S, sale reported on Form 4 | 33,000 | $76.9K | 2023-08-25 | SEC |
| 2025-08-21 | S, sale reported on Form 4 | 54,491 | $155.3K | 2025-08-22 | SEC |
| 2026-01-23 | S, sale reported on Form 4 | 78,968 | $375.1K | 2026-01-27 | SEC |
| 2026-01-26 | S, sale reported on Form 4 | 23,849 | $109.9K | 2026-01-27 | SEC |
| 2026-02-04 | S, sale reported on Form 4 | 1,655 | $7.5K | 2026-02-06 | SEC |
Counted from the Form 4 filings this reporting owner (SEC CIK 1793412) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

